In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
Adverse reactions attributed to entire drug class 'Antipsychotic'
Please login to view adverse reactions.
Bullous pemphigoid / pemphigoid
- (2021): Fabrazzo M+, Brain Sci 11(11), 1386 [REVIEW] (association)
- (2015): Singh LK+, Curr Drug Saf 10(3), 251
Fixed eruption / fixed drug eruption
- (2015): Singh LK+, Curr Drug Saf 10(3), 251
- (2015): Singh LK+, Curr Drug Saf 10(3), 251
- (2015): Singh LK+, Curr Drug Saf 10(3), 251
- (2021): He L+, Front Pharmacol Feb (e-Collection) [REVIEW]
Cardiovascular adverse effect (includes major adverse cardiovascular events (MACE))
- (2024): Gasparini S+, Eur J Pediatr 184(1), 20 [REVIEW]
- (2021): Hanna MP+, Am J Cardiol Nov, Online ahead of print18%
- (2023): Vaziri N+, Schizophr Res 261, 206-215 [REVIEW]
QT interval prolonged / QT prolongation
- (2022): Vaiman EE+, Int J Mol Sci 23(24), 15786 [REVIEW] (pharmacogenomics)
- (2024): Gerolymos C+, JAMA Netw Open 7(3), e241527 [REVIEW]
- (2023): Nasyrova RF+, Genes (Basel) 14(3), 616 [REVIEW] (pharmacogenomics)
- (2021): Santos CD+, Crit Care Nurse 41(3), 50-54 (1 case / male)
- (2018): Pringsheim T+, Can J Psychiatry Jan, Epub ahead of print [REVIEW]
- (2021): Hirjak D+, Mol Psychiatry 26(11), 6112-6114 [REVIEW]
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
Compulsions / obsessive-compulsive symptoms / obsessive-compulsive disorder
- (2023): Burk BG+, Acta Psychiatr Scand 148(1), 32-46 [REVIEW] (pharmacovigilance / pharmacoepidemiology)
- (2022): Friedrich ME+, Int J Neuropsychopharmacol Feb, Online ahead of print [REVIEW]
- (2021): Baumgärtner J+, World J Biol Psychiatry Jun, Online ahead of print
- (2021): Ali T+, PLoS One 16(9), e0257129 [REVIEW]
- (2020): Maeda I+, Gen Hosp Psychiatry 67, 35-4110%
- (2018): Pringsheim T+, Can J Psychiatry Jan, Epub ahead of print [REVIEW]
- (2014): Fratto G+, Int J Psychiatry Med 48(3), 185 [REVIEW]
- (2021): Kamp D+, Hum Psychopharmacol Sep, e2816
- (2017): Karajamaki A+, Duodecim 133(3), 301
Neuroleptic malignant syndrome
- (2024): Miyasaka K+, Cureus 16(8), e68260 (pharmacovigilance / pharmacoepidemiology)
- (2023): Hirofuji S+, Heliyon 9 (11), e21891 (association) (pharmacovigilance / pharmacoepidemiology)
- (2021): Hirjak D+, Mol Psychiatry 26(11), 6112-6114 [REVIEW]
- (2021): Vaiman EE+, Biomedicines 9(8), 879 [REVIEW]
- (2021): Wisidagama S+, Medicines (Basel) 8(6), 24 [REVIEW]
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
Restless legs syndrome / Willis-Ekbom disease (includes restless arms syndrome variant)
- (2022): Elrassas HH+, Hum Psychopharmacol 37(2), e2817
Sleep-related eating disorder (SRED)
- (2021): Gouverneur A+, Br J Clin Pharmacol Mar, Online ahead of print [REVIEW] (association)
Somnambulism (sleepwalking; noctambulism)
- (2021): Gouverneur A+, Br J Clin Pharmacol Mar, Online ahead of print [REVIEW] (association)
- (2021): Martin MU+, Ann Dermatol Venereol Jun, Online ahead of print [REVIEW]
- (2020): Maeda I+, Gen Hosp Psychiatry 67, 35-419%
- (2016): Fang F+, CNS Drugs 30(9), 845-67 [REVIEW]
Stuttering (dysphemia) / stammering
- (2022): Nikvarz N+, World J Psychiatry 12(2), 236-263 [REVIEW]
Tardive syndrome / tardive dyskinesia
- (2023): Saga Y+, Neuropsychopharmacol Rep Oct, Online ahead of print (data from Japanese Adverse Drug Event Report database)
- (2021): Vaiman EE+, Biomedicines 9(8), 879 [REVIEW]
- (2020): Kumsa A+, Clin Pharmacol 12, 179-18715%
- (2017): Bergman H+, Health Technol Assess 21(43), 1 [REVIEW]
- (2016): Fleischhacker WW+, Neuropsychiatr (German) 30(3), 123 [REVIEW]
- (2023): Pereira S+, Endocrinology Jan, Online ahead of print [REVIEW]
- (2024): Hussain Alshabeeb Z+, Curr Drug Saf Mar, Online ahead of print32%
- (2024): Jiang Q+, Front Psychiatry Mar (e-Collection) [REVIEW]
- (2024): Song M+, Int J Clin Pharmacol Ther Oct, Online ahead of print (pharmacovigilance / pharmacoepidemiology)
- (2023): Junqueira DR+, Pharmaceut Med Feb, Online ahead of print [REVIEW]
- (2022): Krøigaard SM+, J Child Adolesc Psychopharmacol Sep, Online ahead of print21% [REVIEW]
- (2022): Tian C+, Breastfeed Med Apr, Online ahead of print [REVIEW]
- (2021): Rusgis MM+, Am J Health Syst Pharm Feb, Online ahead of print [REVIEW]
- (2017): Karajamaki A+, Duodecim 133(3), 301
- (2021): Seifert J+, J Neural Transm (Vienna) Jul, Online ahead of print
- (2021): Takeda K+, Ann Pharmacother Jul, Online ahead of print [REVIEW]
- (2010): Meulendijks D+, Drug Saf 33 (2), 101-14 [REVIEW]
Inappropriate secretion of antidiuretic hormone (SIADH)
- (2021): Takeda K+, Ann Pharmacother Jul, Online ahead of print
Macrophage migration inhibitory factor increased
- (2024): Chen X+, Transl Psychiatry 14(1), 210 (association)
Metabolic syndrome (includes metabolic disorder)
- (2025): Guo Z+, Curr Neuropharmacol 23(4), 439-457 [REVIEW]
- (2023): Akinola PS+, Metab Syndr Relat Disord Jun, Online ahead of print37–63% [REVIEW]
- (2022): Khasanova AK+, Metabolites 12(8), 726 [REVIEW]
- (2021): Libowitz MR+, Front Psychiatry Mar, Online ahead of print [REVIEW]
- (2024): Hegde NC+, Gen Hosp Psychiatry 90, 12-21 [REVIEW]
- (2023): Agarwal SM+, Schizophr Bull Apr, Online ahead of print [REVIEW]
- (2023): Franz M+, J Psychiatr Res 169, 184-190
- (2022): Dobrodeeva VS+, Pharmaceutics 14(2), 222
- (2022): Jürgens G+, J Pers Med 12(10), 1728 (pharmacogenomics)
- (2021): Libowitz MR+, Front Psychiatry Mar, Online ahead of print [REVIEW]
- (2021): Speyer H+, Front Endocrinol (Lausanne) Jul (e-Collection) [REVIEW]
- (2021): Xu Y+, CNS Drugs Aug, Online ahead of print [REVIEW]
Intestinal pseudo-obstruction (Ogilvie syndrome)
- (2025): Ribeiro J+, Cureus 17(3), e80910 (1 case / male)
- (2020): Druschky K+, World J Biol Psychiatry Sep, Online ahead of print (severe) [REVIEW]
Enuresis (urinary incontinence)
- (2021): Arasteh A+, Biomed Pharmacother Oct (e-Collection) [REVIEW]
- (2021): Ivashchenko DV+, Drug Metab Pers Ther Aug, Online ahead of print
- (2021): Hwang T+, Sex Med Rev 9(3), 464-471 [REVIEW]
- (2019): Burk BG+, J Pharm Pract Nov, Epub ahead of print (1 case)
- (2024): Uekusa S+, Drugs Real World Outcomes Nov, Online ahead of print (association) (pharmacovigilance / pharmacoepidemiology)
Agranulocytosis / severe selective neutropenia
- (2023): Glocker C+, J Neural Transm (Vienna) Jan, Online ahead of print
Neutropenia (neutrophils decreased)
- (2023): Glocker C+, J Neural Transm (Vienna) Jan, Online ahead of print
Cervical dystonia / antecollis / spasmodic torticollis
- (2024): Inada T+, J Clin Psychiatry Apr (e-Collection)
- (2025): Ebina T+, Psychiatry Clin Neurosci Jan, Online ahead of print (pharmacovigilance / pharmacoepidemiology)
Laryngospasm (laryngeal dystonia / spasmodic dysphonia)
- (2024): Maguire PA+, Schizophr Res 264, 248-262 (45 cases) [REVIEW]
- (2018): Torbic H+, Pharmacotherapy Feb, Epub ahead of print [REVIEW]
Adverse effects / adverse reactions
- (2022): Guo K+, Front Pharmacol Mar (e-Collection)
- (2021): Ivashchenko DV+, Drug Metab Pers Ther 37(1), 47-53 (pharmacogenetics)
- (2021): Kishi T+, J Psychiatr Res 138, 444-452 [REVIEW]
- (2020): Cicala G+, Front Psychiatry Mar (e-Collection)
- (2020): Montejo AL+, Front Neurosci 14, 509 [REVIEW]
- (2020): Orsolini L+, Expert Opin Drug Saf Jul, Online ahead of print [REVIEW]
- (2020): Solmi M+, World Psychiatry 19(2), 214 [REVIEW]
